Immix Biopharma, Inc.
IMMX
$10.97
$0.050.46%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | -11.56M | -10.09M | -10.69M | -7.59M | -6.62M |
| Total Depreciation and Amortization | 130.90K | 130.80K | 90.60K | 134.90K | 79.80K |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | 939.50K | 599.10K | 570.80K | 470.50K | 532.20K |
| Change in Net Operating Assets | -1.25M | -470.30K | -1.00M | 1.07M | 700.70K |
| Cash from Operations | -11.74M | -9.83M | -11.03M | -5.91M | -5.31M |
| Capital Expenditure | -21.00K | -32.50K | -165.10K | -372.50K | -127.60K |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -- | -- |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | 2.69M | -4.77M | -6.48M | -- | -- |
| Cash from Investing | 2.67M | -4.80M | -6.65M | -372.50K | -127.60K |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | -- | -- |
| Issuance of Common Stock | 155.21M | 33.50K | 95.64M | 10.77M | 1.11M |
| Repurchase of Common Stock | -- | -- | -- | -- | -- |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 71.10K | -71.10K | 29.80K | -166.80K | -- |
| Cash from Financing | 155.28M | -37.60K | 95.67M | 10.61M | 1.11M |
| Foreign Exchange rate Adjustments | 24.70K | -12.80K | -11.70K | -20.60K | 44.10K |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 146.24M | -14.68M | 77.98M | 4.31M | -4.28M |